Danqing Kong Selected Research

Danqing Kong Research Topics

4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2020
1	acquired Thrombotic thrombocytopenic purpura 08/2023
1	Infections 01/2023
1	Thrombotic Thrombocytopenic Purpura 11/2022
1	Acquired amegakaryocytic thrombocytopenia 08/2022
1	Hemophilia A (Haemophilia) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022
1	Residual Neoplasm 10/2020
1	Neoplasms (Cancer) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Anemia 01/2018

3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2020
2	Rituximab (Mabthera)FDA Link 12/2022 - 11/2022
2	Bortezomib (Velcade)FDA Link 11/2022 - 01/2022
2	eltrombopag FDA Link 08/2022 - 01/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 08/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2022
1	Gemcitabine FDA Link 12/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Decitabine FDA Link 01/2022
1	Prostaglandins FIBA 01/2018
1	Thrombopoietin ReceptorsIBA 01/2018